Credit Suisse’s Spyre Therapeutics SYRE Stock Holding History

Credit Suisse’s Portfolio SYRE Stock Details SYRE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$837K	Buy
2022 Q3	–	Sell
2022 Q2	$0	Buy
2021 Q1	–	Sell
2020 Q4	$91K	Buy
2016 Q4	–	Sell
2016 Q3	$64K	Buy